These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35996308)

  • 21. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
    Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
    J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients.
    Toyoshima Y; Takahashi H; Katada S; Kojima N; Tada M; Tani T; Koike R; Nozawa T; Aida I; Nakajima T; Onodera O; Kakita A
    Neuropathology; 2021 Dec; 41(6):450-456. PubMed ID: 34779072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
    Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
    Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide.
    Stamelou M; Quinn NP; Bhatia KP
    Mov Disord; 2013 Aug; 28(9):1184-99. PubMed ID: 23720239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
    Yoshida M
    Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Differential Diagnosis and Treatment of Atypical Parkinsonism.
    Levin J; Kurz A; Arzberger T; Giese A; Höglinger GU
    Dtsch Arztebl Int; 2016 Feb; 113(5):61-9. PubMed ID: 26900156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcranial sonography and [18F]fluorodeoxyglucose positron emission tomography for the differential diagnosis of parkinsonism: a head-to-head comparison.
    Hellwig S; Reinhard M; Amtage F; Guschlbauer B; Buchert R; Tüscher O; Weiller C; Niesen WD; Meyer PT
    Eur J Neurol; 2014 Jun; 21(6):860-6. PubMed ID: 24602186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Case of Pathologically Confirmed Corticobasal Degeneration Initially Presenting as Progressive Supranuclear Palsy Syndrome.
    Chung EJ; Cho HJ; Jang W; Hur DY; Kim YS; Lee KH; Kim SJ
    J Korean Med Sci; 2022 Jun; 37(22):e183. PubMed ID: 35668689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism.
    Chougar L; Arsovic E; Gaurav R; Biondetti E; Faucher A; Valabrègue R; Pyatigorskaya N; Dupont G; Lejeune FX; Cormier F; Corvol JC; Vidailhet M; Degos B; Grabli D; Lehéricy S
    Mov Disord; 2022 Jun; 37(6):1245-1255. PubMed ID: 35347754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lumping and splitting the Parkinson Plus syndromes: dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy, and cortical-basal ganglionic degeneration.
    Mark MH
    Neurol Clin; 2001 Aug; 19(3):607-27, vi. PubMed ID: 11532646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progression of falls in postmortem-confirmed parkinsonian disorders.
    Wenning GK; Ebersbach G; Verny M; Chaudhuri KR; Jellinger K; McKee A; Poewe W; Litvan I
    Mov Disord; 1999 Nov; 14(6):947-50. PubMed ID: 10584668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
    Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
    Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.
    Bhidayasiri R; Sringean J; Reich SG; Colosimo C
    Parkinsonism Relat Disord; 2019 Feb; 59():82-92. PubMed ID: 30409560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progressive supranuclear palsy and corticobasal degeneration: Diagnostic challenges and clinicopathological considerations.
    Eusebio A; Koric L; Félician O; Guedj E; Ceccaldi M; Azulay JP
    Rev Neurol (Paris); 2016; 172(8-9):488-502. PubMed ID: 27561438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into atypical parkinsonism.
    Wenning GK; Krismer F; Poewe W
    Curr Opin Neurol; 2011 Aug; 24(4):331-8. PubMed ID: 21577106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.
    Boeve BF; Silber MH; Ferman TJ; Lin SC; Benarroch EE; Schmeichel AM; Ahlskog JE; Caselli RJ; Jacobson S; Sabbagh M; Adler C; Woodruff B; Beach TG; Iranzo A; Gelpi E; Santamaria J; Tolosa E; Singer C; Mash DC; Luca C; Arnulf I; Duyckaerts C; Schenck CH; Mahowald MW; Dauvilliers Y; Graff-Radford NR; Wszolek ZK; Parisi JE; Dugger B; Murray ME; Dickson DW
    Sleep Med; 2013 Aug; 14(8):754-62. PubMed ID: 23474058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid.
    Boman A; Svensson S; Boxer A; Rojas JC; Seeley WW; Karydas A; Miller B; Kågedal K; Svenningsson P
    J Parkinsons Dis; 2016 Apr; 6(2):307-15. PubMed ID: 27061067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy.
    Lee JH; Han YH; Kang BM; Mun CW; Lee SJ; Baik SK
    J Neurol; 2013 Aug; 260(8):2094-101. PubMed ID: 23670309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.